RxDoctor Payments Data

Crystal Davis, MD

Family Medicine · Jacksonville, FLNPI 1669869681

Payments from drug & device makers

$2,162in general payments, 2019–2025

Across 87 payments — averaging $24.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • KCI USA, Inc.$363
  • AbbVie$349
  • AstraZeneca$291
  • Lilly USA, LLC$277
  • Novo Nordisk$243
  • Pfizer$175
  • plus $464 from 12 others

What the payments were for

  • Travel & lodging$36317%
  • Food & beverage$1,78783%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,162 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$99,643
Medicare patients
201
Services billed
1,194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$57,686
JardianceEmpagliflozin34$37,589
TrulicityDulaglutide14$25,915
EliquisApixaban26$19,485
FarxigaDapagliflozin Propanediol24$19,338
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog22$19,054
XareltoRivaroxaban12$16,247
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,701
Breo ElliptaFluticasone/Vilanterol14$6,496
SymbicortBudesonide/Formoterol Fumarate19$4,304
SynthroidLevothyroxine Sodium17$2,466
Atorvastatin Calcium197$1,894
Levothyroxine Sodium151$1,775
Gabapentin80$1,647
Montelukast Sodium58$1,190

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$243$57,68640 claims
Boehringer IngelheimJardiance$19$37,58934 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$291$30,34354 claims
Lilly USA, LLCTrulicity$277$25,91514 claims
PfizerEliquis$175$19,48526 claims
Johnson & JohnsonXarelto$38$16,24712 claims
GSKBreo Ellipta$77$6,49614 claims
AbbVieSynthroid$349$2,46617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →